Xieer Liang
机构：Nanfang Hospital, Southern Medical University · ORCID：0000-0002-0862-3291
发表论文 81 篇 · 总被引 879 次 · h-index 20
代表论文
- Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B (2024 · New England Journal of Medicine · 被引 81)
- Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort study (2024 · EClinicalMedicine · 被引 23)
- Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection (2026 · New England Journal of Medicine · 被引 20)
- Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: a phase 1 trial with a randomized, placebo-controlled design (2024 · Virology Journal · 被引 6)
- ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial (2026 · The Lancet. Gastroenterology & hepatology · 被引 5)
- Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China (2025 · Alimentary Pharmacology & Therapeutics · 被引 5)